Home » Roche Acquiring Santaris Pharma for Up to $450 Million
Roche Acquiring Santaris Pharma for Up to $450 Million
Roche said Tuesday it will acquire Santaris Pharma for up-to-$450 million, some seven months after the pharma giant and Danish-based biotech launched an up-to-$148 million-plus-per-product alliance designed to discover and develop RNA-targeted oligonucleotide therapeutics using Santaris’ locked nucleic acid (LNA) drug platform.
GEN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May